Collection of Data on the Management of HIV-1 Patients Treated With Antiretroviral Combination Therapy Including the Integrase Inhibitor Raltegravir.
Phase of Trial: Phase IV
Latest Information Update: 01 Jan 2017
At a glance
- Drugs Raltegravir (Primary) ; Antiretrovirals
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms RACING
- Sponsors Merck & Co
- 10 Jun 2017 Biomarkers information updated
- 01 Jan 2017 Results (n=221) assessing QoL outcomes in patients treated with raltegravir, published in the HIV Clinical Trials
- 01 Dec 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.